Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Classical hematology 1

Conditions

Lung Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Squamous Cell Carcinoma of Head and Neck 1Salivary Gland Neoplasms 1Ovarian Neoplasms 1Neutropenia 1Neurotoxicity Syndromes 1Head and Neck Neoplasms 1Drug-Related Side Effects and Adverse Reactions 1Carcinoma, Ovarian Epithelial 1Anemia 1Adenocarcinoma, Bronchiolo-Alveolar 1Adenocarcinoma of Lung 1

Interventions

Carboplatin 15Radiotherapy 13Erlotinib Hydrochloride 11Bevacizumab 10Paclitaxel 9Pemetrexed 8Gemcitabine 8Docetaxel 7Cisplatin 6Gefitinib 4Vinorelbine 3pegfilgrastim 2Topotecan 2Sorafenib 2Irinotecan 2Chemotherapy, Adjuvant 2sargramostim 1romidepsin 1lentiviral minigene vaccine of COVID-19 coronavirus 1irofulven 1cositecan 1Watchful Waiting 1Video-Assisted Surgery 1Thalidomide 1Taxes 1Sunitinib 1Soybean Proteins 1Selenomethionine 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Adenocarcinoma, Bronchiolo-Alveolar × 2,2'-dithiodiethanesulfonic acid × Clear all
NCT00077311 2016-06-30

Docetaxel and Cisplatin With or Without Dimesna in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Alliance for Clinical Trials in Oncology

Phase 2 Completed
160 enrolled
Classical hematologyThoracic

Adenocarcinoma of Lung, Anemia, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neutropenia, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡